Caris Life Sciences, Inc. (CAI)
23.04
-0.92
(-3.84%)
USD |
NASDAQ |
Nov 13, 16:00
23.04
0.00 (0.00%)
After-Hours: 19:59
Caris Life Sciences Price : 23.04 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 24.00 | 24.37 | 22.58 | 23.04 | 3.021M |
| Nov 12, 2026 | 23.66 | 24.32 | 23.05 | 23.96 | 3.572M |
| Nov 11, 2026 | 25.59 | 25.76 | 23.86 | 24.49 | 4.682M |
| Nov 10, 2026 | 25.80 | 25.80 | 23.90 | 24.43 | 5.075M |
| Nov 09, 2026 | 25.29 | 26.02 | 24.60 | 25.57 | 4.902M |
| Nov 06, 2026 | 26.41 | 26.57 | 24.09 | 25.23 | 10.29M |
| Nov 05, 2026 | 27.18 | 27.76 | 25.30 | 26.03 | 7.829M |
| Nov 04, 2026 | 33.51 | 34.10 | 31.88 | 33.22 | 4.094M |
| Nov 03, 2026 | 32.27 | 34.00 | 32.14 | 32.85 | 2.676M |
| Nov 02, 2026 | 34.94 | 35.05 | 32.03 | 32.10 | 3.258M |
| Oct 30, 2026 | 35.30 | 35.71 | 33.71 | 34.33 | 3.673M |
| Oct 29, 2026 | 35.73 | 36.24 | 34.87 | 36.14 | 3.787M |
| Oct 28, 2026 | 33.52 | 36.50 | 33.49 | 35.45 | 4.251M |
| Oct 27, 2026 | 32.40 | 34.06 | 32.07 | 33.67 | 3.381M |
| Oct 26, 2026 | 32.00 | 32.57 | 31.75 | 32.46 | 1.999M |
| Oct 23, 2026 | 31.74 | 32.16 | 30.95 | 32.00 | 2.322M |
| Oct 22, 2026 | 32.00 | 32.61 | 30.33 | 31.71 | 2.423M |
| Oct 21, 2026 | 31.11 | 32.75 | 30.92 | 32.35 | 2.234M |
| Oct 20, 2026 | 30.71 | 31.56 | 30.10 | 31.11 | 3.537M |
| Oct 19, 2026 | 31.26 | 31.99 | 30.62 | 30.71 | 2.103M |
| Oct 16, 2026 | 31.76 | 32.40 | 30.16 | 30.56 | 2.731M |
| Oct 15, 2026 | 29.50 | 32.15 | 28.80 | 31.76 | 3.554M |
| Oct 14, 2026 | 29.23 | 31.53 | 29.02 | 30.26 | 4.347M |
| Oct 13, 2026 | 29.48 | 29.78 | 28.66 | 29.53 | 3.524M |
| Oct 12, 2026 | 29.94 | 30.13 | 28.49 | 29.69 | 4.998M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Natera, Inc. | 319.09 |
| Myriad Genetics, Inc. | 5.66 |
| BioRestorative Therapies, Inc. | 1.49 |
| CareDx, Inc. | 77.88 |
| Exagen, Inc. | 4.13 |
Price Related Metrics
| PE Ratio | 68.21 |
| PS Ratio | 6.282 |
| Price to Book Value | 10.33 |
| Price to Free Cash Flow | 310.58 |
| Earnings Yield | 1.47% |
| Market Cap | 6.606B |
| Operating PE Ratio | 47.05 |
| Normalized PE Ratio | 56.89 |